Les appels du Cluster 1 - Santé

Sommaire

Global Calls for Cluster 1 - Health Projects

HORIZON-HLTH-2025-03-two-stage

Cluster 1 - Health (Two stage - 2025)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage Advancing knowledge on the impacts of micro- and nanoplastics on human health 40 000 000 HORIZON Research and Innovation Actions 22/05/2025
16/09/2025
16/04/2026
193 jours
HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage The impact of pollution on the development and progression of brain diseases and disorders 40 000 000 HORIZON Research and Innovation Actions 22/05/2025
16/09/2025
16/04/2026
193 jours
HORIZON-HLTH-2025-03-DISEASE-02-two-stage Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders 50 000 000 HORIZON Research and Innovation Actions 22/05/2025
16/09/2025
16/04/2026
193 jours
HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage Improving the quality of life of persons with intellectual disabilities and their families 40 000 000 HORIZON Research and Innovation Actions 22/05/2025
16/09/2025
16/04/2026
193 jours
HORIZON-HLTH-2025-03-IND-03-two-stage Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices 40 000 000 HORIZON Research and Innovation Actions 22/05/2025
16/09/2025
16/04/2026
193 jours
Topic(s)
193 jours
Advancing knowledge on the impacts of micro- and nanoplastics on human health
Clôture : 16/09/2025
Clôture (2nde étape) : 16/04/2026
193 jours
The impact of pollution on the development and progression of brain diseases and disorders
Clôture : 16/09/2025
Clôture (2nde étape) : 16/04/2026
193 jours
Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
Clôture : 16/09/2025
Clôture (2nde étape) : 16/04/2026
193 jours
Improving the quality of life of persons with intellectual disabilities and their families
Clôture : 16/09/2025
Clôture (2nde étape) : 16/04/2026
193 jours
Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
Clôture : 16/09/2025
Clôture (2nde étape) : 16/04/2026